Correlation Between SeqLL and Ambrx Biopharma
Can any of the company-specific risk be diversified away by investing in both SeqLL and Ambrx Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL and Ambrx Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SeqLL Inc and Ambrx Biopharma American, you can compare the effects of market volatilities on SeqLL and Ambrx Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL with a short position of Ambrx Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL and Ambrx Biopharma.
Diversification Opportunities for SeqLL and Ambrx Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SeqLL and Ambrx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Inc and Ambrx Biopharma American in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ambrx Biopharma American and SeqLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Inc are associated (or correlated) with Ambrx Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ambrx Biopharma American has no effect on the direction of SeqLL i.e., SeqLL and Ambrx Biopharma go up and down completely randomly.
Pair Corralation between SeqLL and Ambrx Biopharma
If you would invest (100.00) in Ambrx Biopharma American on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Ambrx Biopharma American or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
SeqLL Inc vs. Ambrx Biopharma American
Performance |
Timeline |
SeqLL Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Ambrx Biopharma American |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
SeqLL and Ambrx Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SeqLL and Ambrx Biopharma
The main advantage of trading using opposite SeqLL and Ambrx Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL position performs unexpectedly, Ambrx Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambrx Biopharma will offset losses from the drop in Ambrx Biopharma's long position.SeqLL vs. Agilent Technologies | SeqLL vs. iSpecimen | SeqLL vs. Intelligent Bio Solutions | SeqLL vs. bioAffinity Technologies, |
Ambrx Biopharma vs. Immix Biopharma | Ambrx Biopharma vs. Cns Pharmaceuticals | Ambrx Biopharma vs. Sonnet Biotherapeutics Holdings | Ambrx Biopharma vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |